ArticleFrontiers in genetics2022

Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment.

Xiangxiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.